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In recent years there has been a resurgence of interest among
radiobiologists and radiotherapists in the idea that repopula-
tion by surviving tumour cells during treatment may signifi-
cantly reduce tumour control and that rapidly proliferating
tumours may be better treated by shortening the overall
treatment time. Tumours of a particular histopathological
type differ widely in growth rate and there is therefore a real
need for techniques by which the rapidly growing tumours
(presumed to be those that will repopulate fast) can be
identified.
This book has therefore appeared at an appropriate time
for radiobiologists, but I fear that it may prove disappointing
to them. The application to radiotherapy of cell kinetic tech-
niques is passed over in a couple of pages. The emphasis of
the book is on the use of cell kinetic techniques in tumour
diagnosis, prognosis, and response to chemotherapy.
The eleven chapters are of variable level and quality. We
have a detailed and impressive description of the proteins
involved in regulation of the cell cycle, although necessarily
this deals mostly with xenopus eggs, budding yeast, and fruit
flies. At the other extreme there is a chapter on the counting
of mitotic figures in histological sections of tumour tissue in
terms of mitotic figures per 10 high-power fields. The authors
conclude that this method is flawed by differences in cell size
and the roughly six-fold difference in the size of fields of
different microscopes! Other chapters review the use of H3-
thymidine, flow cytometry, immunohistochemistry, and nu-
clear organiser regions (NORs).
Overall, the treatment of these techniques is honest, per-
haps too honest. Repeatedly we are told of the many
difficulties that frustrate their useful clinical application:
'Despite the vast and ever-expanding literature on pro-
liferative activity, there is almost no clinical situation in
which such information is used on a routine basis. This is
due, firstly, to the lack of simple, cheap, reducible, and easily
applied methods to investigate tumour kinetics. All the
techniques alluded to in this review fail to meet these
criteria . . .'. Predictably, the authors also conclude that there
is an urgent need for further research.
I suspect that the true picture is actually more promising
than some of these authors lead us to believe and that if
there were a strong demand from clinicians to have labora-
tory tests that are predictive of the kinetics of tumour res-
ponse or toxicity, then these would soon emerge. So far there
appears to have been no parallel comparison of a number of
techniques in a single clinical situation, aiming to identify
that which has the greatest predictive potential. The lack of
clinical pressure for predictive assays may perhaps be related
to the difficulty of knowing how to respond to the infor-
mation provided by a predictive test. In the case of radiother-
apy the response is obvious, to shorten the overall treatment
time for rapidly-repopulating tumours. There is considerable
interest among radiotherapists in this idea; it may therefore
be in this area that the assays could have their greatest
clinical impact.
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